| Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine A Vlahou, PF Schellhammer, S Mendrinos, K Patel, FI Kondylis, L Gong, ... The American journal of pathology 158 (4), 1491-1502, 2001 | 629 | 2001 |
| Proteinchip® surface enhanced laser desorption/ionization (SELDI) mass spectrometry: a novel protein biochip technology for detection of prostate cancer biomarkers in complex … GL Wright Jr, LH Cazares, SM Leung, S Nasim, BL Adam, TT Yip, ... Prostate Cancer & Prostatic Diseases 2, 1999 | 386 | 1999 |
| Molecular and proteomic characterization of human mesenchymal stem cells derived from amniotic fluid: comparison to bone marrow mesenchymal stem cells MG Roubelakis, KI Pappa, V Bitsika, D Zagoura, A Vlahou, HA Papadaki, ... Stem cells and development 16 (6), 931-952, 2007 | 367 | 2007 |
| Recommendations for biomarker identification and qualification in clinical proteomics H Mischak, G Allmaier, R Apweiler, T Attwood, M Baumann, A Benigni, ... Science translational medicine 2 (46), 46ps42-46ps42, 2010 | 337 | 2010 |
| Secretome proteomics for discovery of cancer biomarkers M Makridakis, A Vlahou Journal of proteomics 73 (12), 2291-2305, 2010 | 317 | 2010 |
| Diagnosis of ovarian cancer using decision tree classification of mass spectral data A Vlahou, JO Schorge, BW Gregory, RL Coleman BioMed Research International 2003 (5), 308-314, 2003 | 258 | 2003 |
| Diagnosis and prediction of CKD progression by assessment of urinary peptides JP Schanstra, P Zürbig, A Alkhalaf, A Argiles, SJL Bakker, J Beige, ... Journal of the American Society of Nephrology 26 (8), 1999-2010, 2015 | 256 | 2015 |
| Proteomic approaches to biomarker discovery in prostate and bladder cancers BL Adam, A Vlahou, OJ Semmes, GL Wright, Jr PROTEOMICS: International Edition 1 (10), 1264-1270, 2001 | 248 | 2001 |
| Technical aspects and inter-laboratory variability in native peptide profiling: The CE–MS experience H Mischak, A Vlahou, JPA Ioannidis Clinical biochemistry 46 (6), 432-443, 2013 | 222 | 2013 |
| Introduction to population pharmacokinetic/pharmacodynamic analysis with nonlinear mixed effects models JS Owen, J Fiedler-Kelly John Wiley & Sons, 2014 | 210 | 2014 |
| A novel approach toward development of a rapid blood test for breast cancer A Vlahou, C Laronga, L Wilson, B Gregory, K Fournier, D McGaughey, ... Clinical breast cancer 4 (3), 203-209, 2003 | 202 | 2003 |
| Implementation of proteomic biomarkers: making it work H Mischak, JPA Ioannidis, A Argiles, TK Attwood, E Bongcam‐Rudloff, ... European journal of clinical investigation 42 (9), 1027-1036, 2012 | 181 | 2012 |
| Stem cells: insights into the secretome M Makridakis, MG Roubelakis, A Vlahou Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics 1834 (11), 2380-2384, 2013 | 179 | 2013 |
| Comprehensive human urine standards for comparability and standardization in clinical proteome analysis H Mischak, W Kolch, M Aivaliotis, D Bouyssié, M Court, H Dihazi, ... Proteomics–Clinical Applications 4 (4), 464-478, 2010 | 158 | 2010 |
| Pharmacoproteomic analysis of prechemotherapy and postchemotherapy plasma samples from patients receiving neoadjuvant or adjuvant chemotherapy for breast carcinoma L Pusztai, BW Gregory, KA Baggerly, B Peng, J Koomen, HM Kuerer, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2004 | 149 | 2004 |
| Proteomic biomarkers in kidney disease: issues in development and implementation H Mischak, C Delles, A Vlahou, R Vanholder Nature Reviews Nephrology 11 (4), 221-232, 2015 | 139 | 2015 |
| Addressing the challenge of defining valid proteomic biomarkers and classifiers M Dakna, K Harris, A Kalousis, S Carpentier, W Kolch, JP Schanstra, ... BMC bioinformatics 11, 1-16, 2010 | 138 | 2010 |
| A urinary proteome-based classifier for the early detection of decline in glomerular filtration C Pontillo, L Jacobs, JA Staessen, JP Schanstra, P Rossing, ... Nephrology Dialysis Transplantation 32 (9), 1510-1516, 2017 | 132 | 2017 |
| Profilin 1 is a potential biomarker for bladder cancer aggressiveness J Zoidakis, M Makridakis, PG Zerefos, V Bitsika, S Esteban, M Frantzi, ... Molecular & cellular proteomics 11 (4), 2012 | 128 | 2012 |
| A tumor-protective role for human kallikrein-related peptidase 6 in breast cancer mediated by inhibition of epithelial-to-mesenchymal transition G Pampalakis, E Prosnikli, T Agalioti, A Vlahou, V Zoumpourlis, ... Cancer research 69 (9), 3779-3787, 2009 | 123 | 2009 |
